Ken Griffin’s Cano Health, Inc. CANO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-498
Closed -$12.6K 15686
2023
Q3
$12.6K Sell
498
-87
-15% -$7.15K ﹤0.01% 12957
2023
Q2
$81.3K Buy
585
+269
+85% +$34.5K ﹤0.01% 11230
2023
Q1
$28.8K Sell
316
-58
-16% -$7.87K ﹤0.01% 12772
2022
Q4
$51.2K Sell
374
-1,116
-75% -$378K ﹤0.01% 12106
2022
Q3
$1.29M Buy
1,490
+972
+188% +$609K ﹤0.01% 6448
2022
Q2
$227K Sell
518
-1,117
-68% -$582K ﹤0.01% 10437
2022
Q1
$1.04M Buy
1,635
+417
+34% +$263K ﹤0.01% 7604
2021
Q4
$1.08M Sell
1,218
-909
-43% -$955K ﹤0.01% 7747
2021
Q3
$2.7M Buy
2,127
+943
+80% +$1.14M ﹤0.01% 5616
2021
Q2
$1.43M Buy
+1,184
New +$1.6M ﹤0.01% 7424

Other funds holding CANO

Ken Griffin's CANO Position: Q4 2023 in Review

Ken Griffin sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 3,682 shares — an estimated $93.4K sold.

Ken Griffin first reported a position in CANO in Q4 2020 and held it in 11 quarters. The position peaked at $71.3M in Q2 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Ken Griffin reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Ken Griffin sold 3,682 Cano Health, Inc. shares in Q4 2023, an estimated $93.4K.
  • Ken Griffin first reported a position in Cano Health, Inc. in Q4 2020 and held it in 11 quarters.
  • Ken Griffin's Cano Health, Inc. position peaked at $71.3M in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.